Biotransplant(BTRN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN)

BTRN 35.41

0.0%

Nov 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Pseudo Biologist who wrote (334)	8/9/1999 9:21:00 AM
From: LLCF	Read Replies (1) of 1475

At least they're talking about 507 in their press releases: < Along with MedImmune, the Company also reported encouraging Phase I/II data indicating that MEDI-507 provided potential clinical benefit for treatment of steroid-resistant, severe graft- versus-host disease. The GvHD data were presented at the 28th Annual Meeting of the International Society for Experimental Hematology.''> Meanwhile, tick-tock on the cash clock: They burned 1/3 of their cash in 6 months... wonder if they have any big milestones coming? Perhaps when 507 goes into P3. Think I'll give the company a call and see what they say. DAK

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next